The investigational Symplicity™ Renal Denervation System is a minimally invasive device that is being studied in the U.S. for its ability to lower blood pressure by using a catheter-based treatment. If you are a medical professional and have questions about inclusion and exclusion criteria to help determine the eligibility of your patients, please refer to www.symplifyBPtrial.com for additional information, including a list of participating clinical study sites.
Medtronic is committed to research because great science yields great therapies.It's not enough to say a new technology works; you have to prove it. Medtronic is committed to performing scientifically rigorous pre-clinical and clinical studies. Future studies will be aimed at assessing the technology's impact on heart failure, insulin resistance, chronic kidney disease and other diseases characterized by hyperactive sympathetic drive.
If you or your institution would like to learn more about participating in our future research programs, please contact us at RDNclinicaltrials@medtronic.com.
